Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug Target Elucidation Through Isolation and Analysis of Drug-Resistant Mutants in Cryptococcus neoformans

Methods in molecular biology(2023)10.1007/978-1-0716-3155-3_9Source: DataRank Database

Drug Target Elucidation Through Isolation and Analysis of Drug-Resistant Mutants in Cryptococcus neoformans is a research paper published in Methods in molecular biology (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.95)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Joseph Heitman ORCID,Michael J. Hoy ORCID

Live enrichment

PubMed:37024699 PMC:PMC10602406 OpenAlex:https://openalex.org/W4362682897

NIAID NIH HHS

Grant: R56 AI112595

NIAID NIH HHS

Grant: F31 AI150120

NIAID NIH HHS

Grant: R01 AI039115

NIAID NIH HHS

Grant: R37 AI039115

NIAID NIH HHS

Grant: R01 AI050113

National Institutes of Health

Grant: 5R37AI039115-23

Genetics of Cryptococcus sexual reproduction

National Institutes of Health

Grant: 1F31AI150120-01A1

Structure-guided development of fungal specific calcineurin inhibitors

National Institutes of Health

Grant: 2R56AI112595-05

Structural Biological Development of Fungal-Specific Calcineurin Inhibitors

FWCI

1.95

Citation Percentile

0.8%

Citation Trend

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10602406/pdf/nihms-1932915.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/978-1-0716-3155-3_9

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10602406

book serieshttps://doi.org/10.1007/978-1-0716-3155-3_9

Fields of Study

Fungal Infections and StudiesAntifungal resistance and susceptibilityNail Diseases and Treatments0301 basic medicine03 medical and health sciencesHumansCryptococcus neoformansAntifungal AgentsCryptococcosis

MeSH Terms

Antifungal AgentsCryptococcosisCryptococcus neoformansHumans

Keywords

Cryptococcus neoformansDrugAntifungalAntifungal drugAntifungal drugsDrug repositioningCryptococcusIsolation (microbiology)Computational biologyNatural productBiologyDrug discoveryMicrobiologyPharmacologyBioinformaticsBiochemistryMechanism of actiontherapeutic targetWhole-genome SequencingSnp CallingVariant IdentificationSpontaneous MutantsAntifungal AgentsHumansCryptococcosis

Sustainable Development Goals

SDG 0: Good health and well-being